SE8704097D0 - Oral formulation of buspirone and salts thereof - Google Patents
Oral formulation of buspirone and salts thereofInfo
- Publication number
- SE8704097D0 SE8704097D0 SE8704097A SE8704097A SE8704097D0 SE 8704097 D0 SE8704097 D0 SE 8704097D0 SE 8704097 A SE8704097 A SE 8704097A SE 8704097 A SE8704097 A SE 8704097A SE 8704097 D0 SE8704097 D0 SE 8704097D0
- Authority
- SE
- Sweden
- Prior art keywords
- buspirone
- salts
- oral formulation
- bioavailability
- increase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8704097A SE8704097D0 (sv) | 1987-10-22 | 1987-10-22 | Oral formulation of buspirone and salts thereof |
ZA887624A ZA887624B (en) | 1987-10-22 | 1988-10-12 | Oral formulation of buspirone and salts thereof |
IL88020A IL88020A (en) | 1987-10-22 | 1988-10-12 | Oral formulation of buspirone and salts thereof |
AT88850347T ATE108997T1 (de) | 1987-10-22 | 1988-10-17 | Orales präparat von buspiron und seinen salzen. |
JP63508883A JP2674170B2 (ja) | 1987-10-22 | 1988-10-17 | ブスピロンおよびその塩の経口投与用組成物並びにその製造方法 |
KR1019890701101A KR970004906B1 (ko) | 1987-10-22 | 1988-10-17 | 부스피론 및 그의 염의 경구 투여용 제제 |
AU26236/88A AU604585B2 (en) | 1987-10-22 | 1988-10-17 | Oral formulation of buspirone and salts thereof |
ES88850347T ES2056955T3 (es) | 1987-10-22 | 1988-10-17 | Formulacion oral de buspirona y sales de la misma. |
EP88850347A EP0313535B1 (de) | 1987-10-22 | 1988-10-17 | Orales Präparat von Buspiron und seinen Salzen |
DE3850844T DE3850844T2 (de) | 1987-10-22 | 1988-10-17 | Orales Präparat von Buspiron und seinen Salzen. |
PCT/SE1988/000543 WO1989003676A1 (en) | 1987-10-22 | 1988-10-17 | Oral formulation of buspirone and salts thereof |
HU886266A HU204998B (en) | 1987-10-22 | 1988-10-17 | Process for producing peroral pharmaceuticdal compositions comprising buspirone and its salts |
NZ226604A NZ226604A (en) | 1987-10-22 | 1988-10-18 | Sustained release oral formulation containing buspirone as the active ingredient; process for preparation |
NZ238356A NZ238356A (en) | 1987-10-22 | 1988-10-18 | Increasing the bioavailability of buspirone (an azaspirondecanedione) relative to its major metabolite by oral administration of a buspirone controlled/extended release formulation |
IE317788A IE64705B1 (en) | 1987-10-22 | 1988-10-20 | Oral formulation of buspirone and salts thereof |
YU196488A YU47903B (sh) | 1987-10-22 | 1988-10-20 | Postupak za pripremanje oralne formulacije za kontrolisano/produženo oslobadjanje buspirona i njegovih soli |
PT88820A PT88820B (pt) | 1987-10-22 | 1988-10-21 | Processo para a preparacao de composicoes farmaceuticas de libertacao lenta e controlada contendo buspirona ou os seus sais para a administracao por via oral |
DK294489A DK294489A (da) | 1987-10-22 | 1989-06-15 | Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf |
NO89892512A NO892512L (no) | 1987-10-22 | 1989-06-16 | Oralt preparat av buspiron og salter derav. |
FI893017A FI100303B (fi) | 1987-10-22 | 1989-06-20 | Menetelmä suun kautta annettavan buspironin ja sen suolan valmistamise ksi |
MX9203372A MX9203372A (es) | 1987-10-22 | 1992-06-25 | Composiciones farmaceuticas de buspirona y sales de la misma, de aplicacion oral. |
SG144094A SG144094G (en) | 1987-10-22 | 1994-10-05 | Oral formulation of buspirone and salts thereof |
HK21295A HK21295A (en) | 1987-10-22 | 1995-02-16 | Oral formulation of buspirone and salts thereof |
CY181495A CY1814A (en) | 1987-10-22 | 1995-10-20 | Oral formulation of buspirone and salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8704097A SE8704097D0 (sv) | 1987-10-22 | 1987-10-22 | Oral formulation of buspirone and salts thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SE8704097D0 true SE8704097D0 (sv) | 1987-10-22 |
Family
ID=20369959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8704097A SE8704097D0 (sv) | 1987-10-22 | 1987-10-22 | Oral formulation of buspirone and salts thereof |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0313535B1 (de) |
JP (1) | JP2674170B2 (de) |
KR (1) | KR970004906B1 (de) |
AT (1) | ATE108997T1 (de) |
AU (1) | AU604585B2 (de) |
CY (1) | CY1814A (de) |
DE (1) | DE3850844T2 (de) |
DK (1) | DK294489A (de) |
ES (1) | ES2056955T3 (de) |
FI (1) | FI100303B (de) |
HK (1) | HK21295A (de) |
HU (1) | HU204998B (de) |
IE (1) | IE64705B1 (de) |
IL (1) | IL88020A (de) |
NO (1) | NO892512L (de) |
NZ (1) | NZ226604A (de) |
PT (1) | PT88820B (de) |
SE (1) | SE8704097D0 (de) |
WO (1) | WO1989003676A1 (de) |
YU (1) | YU47903B (de) |
ZA (1) | ZA887624B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU208495B (en) * | 1990-06-27 | 1993-11-29 | Alkaloida Vegyeszeti Gyar | Process for producing retarde pharmaceutical compositions |
US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
US5631017A (en) * | 1993-03-26 | 1997-05-20 | Beth Israel Deaconess Medical Center, Inc. | Topical application of buspirone for treatment of pathological conditions associated with immune responses |
DE4341156C2 (de) * | 1993-12-02 | 1997-11-13 | Wacker Chemie Gmbh | Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
GB9706089D0 (en) * | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
DK1017392T3 (da) * | 1997-09-25 | 2002-10-21 | Bayer Ag | Lægemiddel |
US6268368B1 (en) * | 2000-03-01 | 2001-07-31 | American Pharmaceuticals International | Anionic exchange polymer complexes of buspirone |
CN117257747B (zh) * | 2023-11-21 | 2024-01-30 | 泊诺(天津)创新医药研究有限公司 | 一种盐酸丁螺环酮片及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
SE353229B (de) * | 1970-06-04 | 1973-01-29 | Haessle Ab | |
US4182703A (en) * | 1978-01-09 | 1980-01-08 | Eastman Kodak Company | Biheterocyclic ultraviolet stabilizers and their use in organic compositions |
US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
US4693895A (en) * | 1984-10-26 | 1987-09-15 | Alza Corporation | Colon delivery system |
US4634703A (en) * | 1985-10-25 | 1987-01-06 | Bristol-Myers Company | Method for alleviation of panic disorders |
US4640921A (en) * | 1986-02-04 | 1987-02-03 | Bristol-Myers | Treatment of sexual dysfunction with buspirone |
-
1987
- 1987-10-22 SE SE8704097A patent/SE8704097D0/xx unknown
-
1988
- 1988-10-12 ZA ZA887624A patent/ZA887624B/xx unknown
- 1988-10-12 IL IL88020A patent/IL88020A/xx unknown
- 1988-10-17 ES ES88850347T patent/ES2056955T3/es not_active Expired - Lifetime
- 1988-10-17 KR KR1019890701101A patent/KR970004906B1/ko not_active IP Right Cessation
- 1988-10-17 DE DE3850844T patent/DE3850844T2/de not_active Expired - Fee Related
- 1988-10-17 JP JP63508883A patent/JP2674170B2/ja not_active Expired - Fee Related
- 1988-10-17 AU AU26236/88A patent/AU604585B2/en not_active Ceased
- 1988-10-17 EP EP88850347A patent/EP0313535B1/de not_active Expired - Lifetime
- 1988-10-17 HU HU886266A patent/HU204998B/hu not_active IP Right Cessation
- 1988-10-17 WO PCT/SE1988/000543 patent/WO1989003676A1/en active IP Right Grant
- 1988-10-17 AT AT88850347T patent/ATE108997T1/de not_active IP Right Cessation
- 1988-10-18 NZ NZ226604A patent/NZ226604A/en unknown
- 1988-10-20 YU YU196488A patent/YU47903B/sh unknown
- 1988-10-20 IE IE317788A patent/IE64705B1/en not_active IP Right Cessation
- 1988-10-21 PT PT88820A patent/PT88820B/pt active IP Right Revival
-
1989
- 1989-06-15 DK DK294489A patent/DK294489A/da not_active Application Discontinuation
- 1989-06-16 NO NO89892512A patent/NO892512L/no unknown
- 1989-06-20 FI FI893017A patent/FI100303B/fi not_active IP Right Cessation
-
1995
- 1995-02-16 HK HK21295A patent/HK21295A/xx not_active IP Right Cessation
- 1995-10-20 CY CY181495A patent/CY1814A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HU886266D0 (en) | 1991-01-28 |
ZA887624B (en) | 1989-06-28 |
KR970004906B1 (ko) | 1997-04-08 |
FI100303B (fi) | 1997-11-14 |
FI893017A (fi) | 1989-06-20 |
IE883177L (en) | 1989-04-22 |
HK21295A (en) | 1995-02-24 |
ES2056955T3 (es) | 1994-10-16 |
DE3850844D1 (de) | 1994-09-01 |
ATE108997T1 (de) | 1994-08-15 |
AU2623688A (en) | 1989-05-23 |
PT88820B (pt) | 1993-01-29 |
NO892512D0 (no) | 1989-06-16 |
WO1989003676A1 (en) | 1989-05-05 |
YU47903B (sh) | 1996-05-20 |
DK294489D0 (da) | 1989-06-15 |
AU604585B2 (en) | 1990-12-20 |
HU204998B (en) | 1992-03-30 |
IE64705B1 (en) | 1995-08-23 |
IL88020A (en) | 1993-08-18 |
EP0313535A1 (de) | 1989-04-26 |
DK294489A (da) | 1989-06-15 |
EP0313535B1 (de) | 1994-07-27 |
YU196488A (en) | 1990-04-30 |
DE3850844T2 (de) | 1994-12-08 |
KR890701087A (ko) | 1989-12-19 |
JPH02501744A (ja) | 1990-06-14 |
CY1814A (en) | 1995-10-20 |
IL88020A0 (en) | 1989-06-30 |
FI893017A0 (fi) | 1989-06-20 |
NO892512L (no) | 1989-06-16 |
NZ226604A (en) | 1991-07-26 |
JP2674170B2 (ja) | 1997-11-12 |
HUT54495A (en) | 1991-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK367687D0 (da) | Farmaceutisk praeparat til oral indgift med reguleret afgivelse og forlaenget virkning | |
IT1191674B (it) | Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale | |
ATE161836T1 (de) | 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate | |
FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
DE69206495D1 (de) | Matrixtablette zur verlängerten Indapamidfreisetzung nach oraler Gabe. | |
ES2062610T3 (es) | Compuesto diarilico anti-ateroesclerotico. | |
SE8704097D0 (sv) | Oral formulation of buspirone and salts thereof | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
LV10267A (lv) | Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai | |
NO171857C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater | |
NO169835C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive katecholkarboksylderivater | |
NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
NO870950D0 (no) | Fremgangsmaate for fremstilling av et stabilt injiserbart farmasoeytisk preparat. | |
NO172120C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler | |
BE880648A (fr) | Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation | |
MX9203614A (es) | Formulacion farmaceutica de liberacion controlada para administracion oral. | |
SE9002067D0 (sv) | The pharmacological use of certain cystine derivatives | |
NO170017C (no) | Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater | |
NO171210C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indenofuran-derivater |